# Subclinical AtrIal FibrilLation and StrokE PreveNtion Trial

Study · id `cardio:ct-nct02004509` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02004509](<https://clinicaltrials.gov/study/NCT02004509>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02004509

Browse, organ or system: Heart; Brain  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 2054 participants.

## Technical summary

Registry record NCT02004509. Randomized; no masking; primary purpose treatment. Start 2015-02-06 (actual); primary completion 2025-10-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 2054 participants (planned count; ClinicalTrials.gov record NCT02004509, source copy `cardio:ctgov-nct02004509-2021-09-01`, retrieved 2026-10-26)
- Started: 2015-02-06 (actual) (ClinicalTrials.gov record NCT02004509, source copy `cardio:ctgov-nct02004509-2021-09-01`, retrieved 2026-10-26)
- Primary completion: 2025-10-31 (anticipated) (ClinicalTrials.gov record NCT02004509, source copy `cardio:ctgov-nct02004509-2021-09-01`, retrieved 2026-10-26)
- Completion: 2025-10-31 (anticipated) (ClinicalTrials.gov record NCT02004509, source copy `cardio:ctgov-nct02004509-2021-09-01`, retrieved 2026-10-26)
- Countries: Brazil (ClinicalTrials.gov record NCT02004509, source copy `cardio:ctgov-nct02004509-2021-09-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02004509-2021-09-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: Subclinical AtrIal FibrilLation and StrokE PreveNtion Trial
- Acronym: SILENT
- Condition: Atrial Fibrillation
- Intervention (Drug): Anticoagulant
- Lead sponsor: InCor Heart Institute
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Anticoagulants (`cardio:anticoagulants`)
- Registry lists this organization as the lead sponsor: InCor Heart Institute (`cardio:org-incor-heart-institute`)

## Provenance

Content hash: 1bc2ecbe86b3394c973e7e9d4bfaa0b0a7994922a530bd758fc8c3f7b52ba4fc
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
